Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat. - Test2 - elhamkhani - TriplyDB

Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat.

Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat.

http://www.wikidata.org/entity/Q34125053

about

Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.Renal Drug Transporters and Drug Interactions.

P2860

Q36972804-8CF02010-CC4C-4544-9301-4B1B13FCF104 Q38888365-49D10F5E-8A27-4DBA-9ADA-B2D83825AA45 Q39140289-01F19CFE-D9DD-43D7-8470-36FFC7369DCC

P2860

Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat.

http://www.wikidata.org/entity/Q34125053

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Role of multidrug resistance-a ...... patically derived enalaprilat.

@ast

Role of multidrug resistance-a ...... patically derived enalaprilat.

@en

Role of multidrug resistance-a ...... patically derived enalaprilat.

@nl

type

label

Role of multidrug resistance-a ...... patically derived enalaprilat.

@ast

Role of multidrug resistance-a ...... patically derived enalaprilat.

@en

Role of multidrug resistance-a ...... patically derived enalaprilat.

@nl

prefLabel

Role of multidrug resistance-a ...... patically derived enalaprilat.

@ast

Role of multidrug resistance-a ...... patically derived enalaprilat.

@en

Role of multidrug resistance-a ...... patically derived enalaprilat.

@nl

P1433

Q34125053-B2D3E186-1BA8-4B3D-8904-2407BC9A8607

P1476

Q34125053-6EE1406C-20E4-4837-AA9E-44F42639360F

P2093

Q34125053-B636F8A2-C1F1-4328-88CF-3007BCB1FEA1

Q34125053-C36CC94A-F019-48AA-AC73-8D000B230F44

Q34125053-F1CAA7DB-BC32-43EF-91F1-4319EBAFAB7A

P2860

Q34125053-05C3E065-B6BC-446C-91D2-C54C91032998

Q34125053-07914283-3A07-49D4-BA33-07B73263C445

Q34125053-0EE18F5E-AAF9-4E87-A3A0-5068BB22F3A3

Q34125053-1A4C5160-A48E-4F1A-9DA2-DFBF572C1864

Q34125053-24635304-5048-4AC3-A4DD-4D7F1240D31B

Q34125053-3312E8C9-33EB-4428-8CAE-CB7D2F4147A3

Q34125053-3F69A73A-5F2C-4B32-9C70-DCBCF8A0E416

Q34125053-44D0BA1B-2E9D-4F01-951F-BF78169BB187

Q34125053-4532EA4F-1B44-4EF5-9B5B-348B9C54DCAD

Q34125053-4C9508E9-DED3-4C38-8884-3E051B9BE921

P304

Q34125053-9053E6AE-924D-414E-9A62-1E4EC4BD3BE4

P31

Q34125053-1F86EC2A-A384-41FE-B524-8808FF7F76EB

P356

Q34125053-527A65B8-F130-4F2C-AE0B-0570690969A9

P433

Q34125053-37192393-E540-49C3-93BA-D72CBDC62AC2

P478

Q34125053-2A55AD31-8F9A-4AA2-AA4D-CF36FA2F99E9

P50

Q34125053-0104CDC4-600A-4A2C-93B7-76C39D3AE272

P577

Q34125053-A52605C6-978E-4786-B9C4-57B6B2FE74DD

P5875

Q34125053-023B6F65-7011-4D8B-B0CF-A9ABEC53DAAB

P698

Q34125053-4ADDAB46-3BB9-4D17-8CA9-6AA2FF1B633F

P921

Q34125053-D651E852-3833-4228-83B0-07A44D47D64A

P932

Q34125053-4AFD60DA-9399-476D-A186-40B580D09B87

P356

P1433

Drug Metabolism and Disposition

P1476

Role of multidrug resistance-a ...... epatically derived enalaprilat

@en

P2093

Arlene S Bridges

http://www.w3.org/2001/XMLSchema#string

Brian C Ferslew

http://www.w3.org/2001/XMLSchema#string

Kathleen Köck

http://www.w3.org/2001/XMLSchema#string

P2860

Mycophenolic acid plasma concentrations: influence of comedication.

Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

A new class of angiotensin-converting enzyme inhibitors.

The physiological disposition and metabolism of enalapril maleate in laboratory animals.

Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.

Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.

Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.

Effect of culture time on the basal expression levels of drug transporters in sandwich-cultured primary rat hepatocytes

Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease.

Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-s

P304

1567-1574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/DMD.114.057554

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263355280

http://www.w3.org/2001/XMLSchema#string

P698

24958844

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

4152871

http://www.w3.org/2001/XMLSchema#string